Market movement to be limited in coming quarter; be neutral on pharma: Amit Khurana
Amit Khurana, Head of Institutional Equities, Dolat Capital, says market movement is expected to be limited in the coming quarter. Headwinds will create a cooling period before buying resumes. Upside potential is capped, while downside risk is protected. The pharma sector faces challenges in FY26 due to normalizing tailwinds and US trade tariffs. A neutral … Read more